scholarly article | Q13442814 |
P50 | author | Thomas McGlashan | Q7792302 |
P433 | issue | 2 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | schizophrenia | Q41112 |
P304 | page(s) | 167-76 | |
P577 | publication date | 1986-02-01 | |
P1433 | published in | JAMA Psychiatry | Q635830 |
P1476 | title | The prediction of outcome in chronic schizophrenia. IV. The Chestnut Lodge follow-up study | |
P478 | volume | 43 |
Q37886136 | Does olanzapine warrant clinical pharmacokinetic monitoring in schizophrenia? |
Q47773155 | Empowerment and its associations in schizophrenia: a cross-sectional study |
Q34186174 | Influence of duration of untreated psychosis on the short-term outcome of drug-free schizophrenia patients |
Q37516094 | Influencing Factors and Predictors of Early Response in Schizophrenia Patients Receiving the Paliperidone Extended-Release Tablets (Paliperidone ER) |
Q47621817 | Motor Abnormalities: From Neurodevelopmental to Neurodegenerative Through "Functional" (Neuro)Psychiatric Disorders |
Q34078005 | Patient compliance with drug therapy in schizophrenia. Economic and clinical issues |
Q26859165 | Predictors of outcome in early-onset psychosis: a systematic review |
Q34254426 | Testing trait depression as a potential clinical domain in schizophrenia |
Search more.